Cargando…
In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure
The only drugs approved by the US Food and Drug Administration for oral treatment of trichomoniasis belong to the 5-nitroimidazole group. Most individuals infected with Trichomonas vaginalis can be cured with a standard treatment of metronidazole or tinidazole, but it is estimated that more than 159...
Autores principales: | Augostini, Peter, Bradley, Erin L. P., Raphael, Brian H., Secor, W. Evan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175203/ https://www.ncbi.nlm.nih.gov/pubmed/36849257 http://dx.doi.org/10.1097/OLQ.0000000000001788 |
Ejemplares similares
-
In Vitro Susceptibility of Iranian Isolates of Trichomonas vaginalis to Metronidazole
por: MATINI, Mohammad, et al.
Publicado: (2016) -
Transcriptional profile of Trichomonas vaginalis in response to metronidazole
por: Xie, Yiting, et al.
Publicado: (2023) -
Effect of the Symbiosis with Mycoplasma hominis and Candidatus Mycoplasma Girerdii on Trichomonas vaginalis Metronidazole Susceptibility
por: Margarita, Valentina, et al.
Publicado: (2022) -
Identification of Trichomonas vaginalis 5-Nitroimidazole Resistance Targets
por: Graves, Keonte J., et al.
Publicado: (2023) -
Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women
por: Mabaso, Nonkululeko, et al.
Publicado: (2021)